Home > Newsletters > The QMN Weekly Bulletin > FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
The QMN Weekly Bulletin
June 1, 2012 | Vol. 4 No. 22
FDA Warns on Counterfeit Adderall Entering U.S. Via Internet Pharmacies
Rogue online pharmacies looking to cash in on drugs in short supply are peddling counterfeit versions of Teva’s attention-deficit/hyperactivity disorder drug Adderall, the FDA warns. Teva discovered the sales of Adderall (dextroamphetamine/amphetamine) 30-mg tablets containing the wrong active ingredients when patients alerted the company to errors in product packaging, Teva spokeswoman Denise Bradley said Wednesday. The company has reported the matter to the FDA and is working with the agency on the investigation, Bradley added.
Drug Industry Daily
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.